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Abstract:  Application  of  photothermal  Optical  Coherence  Tomography 
(OCT) to detect macrophages in ex vivo rabbit arteries which have engulfed 
nanoclusters  of  gold  coated  iron  oxide  (nanorose)  is  reported.  Nanorose 
engulfed by macrophages associated with atherosclerotic lesions in rabbit 
arteries absorb incident laser (800nm) energy and cause optical pathlength 
(OP) variation which is measured using photothermal OCT. OP variation in 
polydimethyl siloxane tissue phantoms containing varying concentrations of 
nanorose match values predicted from nanoparticle and material properties. 
Measurement  of  OP  variation  in  rabbit  arteries  in  response  to  laser 
excitation provides an estimate of nanorose concentration in atherosclerotic 
lesions  of  2.5x10
9  particles/ml.  OP  variation  in  atherosclerotic  lesions 
containing macrophages taking up nanorose has a different magnitude and 
profile from that observed in control thoracic aorta without macrophages 
and  is  consistent  with  macrophage  presence  as  identified  with  RAM-11 
histology staining. Our results suggest that tissue regions with macrophages 
taking up nanorose can be detected using photothermal OCT. 
©2010 Optical Society of America 
OCIS codes: (170.4500) Optical Coherence Tomography; (170.3880) Medical and Biological 
Imaging. 
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1. Introduction 
Nanoparticles are finding increased application in the biomedical and clinical sciences for 
diagnostics [1] and therapeutics [2]. Although nanoparticles with various geometries and sizes 
have been synthesized and investigated in animal studies, interest has focused on particles less 
than 30-50nm in size because of improved targeting in part due to longer circulation times 
[3,4].  In  vivo  cellular  imaging  of  tissues  has  emerged  as  a  novel  diagnostic  tool  in  wide 
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cellular imaging studies did not incorporate nanoparticles, later studies suggest that substantial 
contrast  enhancement  may  be  achieved  using  nanoparticles  [9].  Optical  properties  of 
nanoparticles including absorption and scattering cross section have been computed using Mie 
theory [10] and the discrete dipole approximation [11]. Importantly these studies conclude 
that for nanoparticles in the clinically important range of 30-50nm, absorption dominates over 
scattering in contrast to larger sized particles in which scattering cross sections are relatively 
larger. 
Currently,  confocal  microscopy  imaging  of  tissues  with  nanoparticles  for  contrast 
enhancement  is  typically  limited  by  a  penetration  depth  of  200  microns  or  less  which  is 
insufficient for many diagnostic applications. To overcome this limitation, Huang et. al. [12] 
and  Fercher  et.  al.  [13]  demonstrated  a  non-contact  diagnostic  method  called  optical 
coherence tomography (OCT). OCT provides a large penetration depth of up to 1-2 mm in 
tissues  with  a  longitudinal  spatial  resolution  of  typically  10-15  µm.  Gobin  et.  al.  [14] 
demonstrated use of nanoparticles to enhance scattering contrast in OCT for detecting cellular 
targets in in vivo tissues. In this study, PEG enhanced gold nanoshells (143 nm diameter, core 
diameter  119nm)  were  injected  intravascularly  in  tumor  bearing  mice  and  allowed  to 
accumulate in malignant tissues passively through the leaky tumor vasculature. Backscattering 
of NIR light increased in dermal regions containing nanoparticles relative to controls where 
light  was  more  strongly  attenuated.  Similarly,  Kirillin  et.  al.  [15]  used  gold  nanoshells 
(75nm/25nm  core  radius/shell  thickness)  as  enhanced  contrast  agents  for  intensity  OCT 
imaging of porcine skin. Because the nanoparticles used in these studies were larger than 
50nm, translation to in vivo clinical applications may be complicated by clearance concerns. 
Smaller particles permeate barriers more rapidly. Reducing nanoparticle size below 50nm for 
reduced clearance by the reticuloendothelial system is expected to render optical properties 
with absorption dominant to scattering and reducing OCT contrast [3]. 
In recent years, interest in phase sensitive OCT has increased [16]. In contrast to intensity 
OCT which measures only the intensity of backscattered light, phase sensitive OCT measures 
both  the  amplitude  and  phase  of  back  scattered  light.  By  measuring  nanometer  scale 
displacements in tissue in response to an external excitation, phase sensitive OCT provides 
additional functionality compared to intensity OCT, which is limited to micron resolution. 
Swept source phase-sensitive OCT achieves a high SNR (signal-to-noise ratio) and fast A-
scan  acquisition  rates  (up  to  370  KHz)  and  allows  detection  of  rapid  changes  in  optical 
pathlength on the nanometer length scales in response to an external excitation. Oldenburg et 
al. [17,18] and Oh et. al [19] used phase sensitive OCT combined with an external magnetic 
field excitation to detect magnetic nanoparticles in tissue. 
Photothermal OCT provides molecular contrast by combining phase sensitive OCT with 
laser excitation of targeted chromophores to measure optical pathlength (OP) variation. By 
targeting  endogenous  or  exogenous  (e.g.  nanoparticles)  chromophores  by  laser  excitation, 
photothermal OCT can provide molecular contrast for clinical diagnostic imaging. Adler et al 
[20]  have  demonstrated  use  of  photothermal  OCT  to  measure  optical  pathlength  (OP) 
variation  in  a  translucent  solution  containing  gold  nanoshells  (120  nm  core,  16  nm)  in 
response to 808nm excitation. In 2008, Skala et al [21] demonstrated use of depth resolved 
photothermal OCT to image OP variation due to gold nanospheres that absorb at 532 nm in a 
cell monolayer and three dimensional tissue constructs. In 2010, Zhou et.al [22]. demonstrated 
application  of  photothermal  OCT  to  image  ex  vivo  breast  tissue  containing  injected  gold 
nanoparticles.  Kim  et  al.  [23]  demonstrated  the  use  of  a  time-domain  photothermal  OCT 
system for detection of superparamagnetic iron oxide nanoparticles in a tissue phantom. Thus, 
previous studies have not made an attempt to estimate nanoparticle concentrations. 
In  this  paper,  we  demonstrate  a  new  method  -  depth  resolved  photothermal  OCT—to 
detect and estimate concentration of nanoparticles in tissue phantoms and macrophage rich 
rabbit  aortas.  We  use  a  novel  magnetic  nanoparticle  cluster  [20]—‘nanorose’  (~30nm  in 
size)—that acts as an exogenous chromophore in tissue with a large absorption cross section 
in the NIR with the possibility of magnetic manipulation and imaging [24]. Because in the 30-
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an optical contrast agent for clinical diagnostics may be enhanced because photothermal OCT 
is based on absorption rather than scattering. We demonstrate here for the first time that depth 
resolved photothermal OCT can be used to detect and provide an estimate of nanoparticle 
concentration  in  scattering  tissue  phantoms  and  atherosclerotic  rabbit  aorta.  We  show 
experimentally  that  intravascular  injection  of  nanorose  combined  with  depth  resolved 
photothermal OCT may be applied to detect macrophages that have engulfed nanorose in 
atherosclerotic ex vivo rabbit aorta. 
2. Materials and methods 
2.1 Nanorose 
Novel clustered iron oxide/gold nanoparticles coated with dextran, we refer to as ‘nanorose’, 
were used as contrast agents [24]. The nanorose are spectrally tuned to give high absorption at 
800nm and longer wavelengths in the near infrared. At 800nm, nanorose absorption cross 
section  is  substantially  larger  than  the  scattering  cross  section  [24].  The  800nm  laser 
excitation  wavelength  was  selected  for  studies  reported  here  to  reduce  absorption  by 
competing  endogenous  chromophores  in  tissue  (e.g.,  hemoglobin)  while  maximizing 
absorption by nanorose. 
2.2 Tissue phantoms 
Tissue phantoms were constructed from poly dimethyl siloxane (PDMS) and rutile TiO2 as a 
scattering  center  with  an  average  particle  size  of  1  micron.  Absorption  and  scattering 
coefficients  of  the  phantoms  were  matched  to  reported  values  for  human  aorta  [25]  by 
computing TiO2 concentration using a Mie scattering calculator [26]. Phantoms with uniform 
thickness (250  m) were prepared using a glass microscope slide as a substrate. Five types of 
tissue phantoms were prepared with variable nanorose concentration: 1) a control without 
nanorose;  2)  20ppm  (ppm  represents  parts  per  million  of  gold  concentration)  giving  a 
concentration  of  6.4  x10
9  nanorose/ml;  3)  10ppm  giving  a  concentration  of  3.2  x10
9 
nanorose/ml; 4) 1 ppm giving a concentration of 3.2x10
8 nanorose/ml; and 5) 0.1 ppm giving 
a concentration of 3.2x10
7 nanorose/ml. 
2.3 Rabbit aorta 
Fat-fed balloon injured New Zealand white rabbits [27] were used as an animal model of 
atherosclerosis for photothermal OCT measurements of nanorose injected intravenously and 
subsequently engulfed by plaque-based macrophages in response to 800nm laser excitation. 
All experimental procedures were performed in accordance with protocols approved by the 
University of Texas Institutional Animal Care and Use Committee. Macrophage-rich lesions 
were induced in New Zealand white rabbits by double balloon injury of the abdominal aorta 
and  high  cholesterol  fat  feeding  as  previously  reported  by  Feldman  and  associates  [27]. 
Briefly, following 2 ½ months of a high fat diet, and a protocol which included balloon de-
endothelialization of the abdominal at 2 weeks, and balloon angioplasty of the abdominal 
aorta at 4 weeks, rabbits were ready for intravenous injection of the nanorose. New Zealand 
white rabbits (age = 6 months, weight = 3 kg, n = 3) were sedated with 2% isofluorane and 
10cc  of  colloidal  nanorose  suspensions  (1.4  mg  Au  /  kg  body  weight)  was  injected 
intravenously into the ear veins. The administered gold dosage is approximately equal to the 
maximum currently allowed in humans by the United States FDA for treatment of rheumatoid 
arthritis [28]. Three days following nanorose injection, animals were euthanized with a lethal 
dose  of  sodium  pentobarbital  (120  mg/kg).  Abdominal  and  thoracic  aorta  were  removed, 
flushed with saline, and cut into 1x1 cm
2 square-sized specimens for photothermal OCT M-
Mode imaging. 
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Fig. 1. (a). Diagram of photothermal OCT experimental setup. (b) Identification of “hot spot” 
in recorded infrared image 
2.4 Photothermal OCT measurements 
2.4.1 Photothermal OCT system 
We designed and constructed a swept source photothermal OCT system that uses a hydrogen-
fluoride gas-cell to trigger A-scan acquisitions. The tunable swept-source laser has emission 
centered  at  1328nm  with  a  bandwidth  of  100nm  and  a  20kHz  A-scan  rate  (Santec  HSL-
10000). The axial coherence length of the system is 21 microns in air. A real-time external 
clock eliminated requirement for post-acquisition interpolation of spectral fringe data [29]. 
We designed and developed real-time acquisition software, which allows display of acquired 
M-mode images at video rates (up to 100Hz). Additional specifications of the system are 
described elsewhere [30]. 
The photothermal OCT experimental setup [Fig. 1(a)] used a customized fixture designed 
to minimize random phase variations from the environment and maintain the sample holder in 
a mechanically fixed position relative to the reference surface. The photothermal OCT beam 
is incident on the specimen from the top and records M-mode images of optical pathlength 
(OP) variation in the specimen in response to laser (800 nm) excitation. An 800nm diode laser 
co-aligned and oppositely directed to the OCT beam was used to excite the specimen. Laser 
excitation was set at 2W and intensity-modulated (fl = 50Hz) with a duty cycle of 50%. The 
laser excitation spot diameter on the back surface of the tissue specimen was fixed at 2mm 
giving an incidence fluence rate of 64W/cm
2. 
2.4.2 Tissue phantom photothermal OCT measurements 
Tissue phantoms were inserted into the fixture, irradiated with intensity-modulated (fl = 50Hz) 
laser (800nm) light and photothermal OCT M-mode images recorded. Tissue phantoms were 
irradiated for 5 seconds and photothermal OCT M-mode images were recorded at an A-scan 
rate of 20kHz with a fringe data sampling rate of approximately 20MS/s. Photothermal OCT 
M-Mode  images  consist  of  100,000  successive  A-scans  recorded  over  a  five-second  time 
period without translating the OCT beam on the specimen. Surface (z = 0) and depth-resolved 
optical pathlength (OP) variation (δ(z,t)) was computed from recorded photothermal OCT M-
mode images using customized software developed in our laboratory. Optical depth (z) is the 
product of refractive index and physical depth [31]. OP (δ(z,t)) is the time-resolved variation 
in  optical  depth  (z)  in  the  specimen.  Surface  and  depth-resolved  peak-to-peak  optical 
pathlength modulation amplitude (OPMA, (δ(z,fl)) was computed from recorded photothermal 
OCT M-mode images. OPMA was determined from the fast Fourier transform of the OP 
variation at the laser (800nm) modulation frequency (fl). OPMA is the peak-to-peak variation 
in optical pathlength at the laser excitation  frequency (fl = 50 Hz) at optical depth z and 
(C) 2010 OSA 02 August 2010 / Vol. 1,  No. 1 / BIOMEDICAL OPTICS EXPRESS  6
#127945 - $15.00 USD Received 6 May 2010; revised 4 Jun 2010; accepted 8 Jun 2010; published 28 Jun 2010averaged over the photothermal OCT M-mode acquisition period and is referenced as (δ(z,fl)) 
in the following discussion. 
2.4.3 Rabbit aorta photothermal OCT measurements 
In  photothermal  OCT  M-mode  imaging  of  macrophage-rich  rabbit  abdominal  aorta,  a 
preliminary  step  involved  identifying  candidate  regions  for  imaging  that  had  taken  up 
nanorose.  To  identify  candidate  regions  for  photothermal  OCT  imaging,  the  aorta  tissue 
sections were irradiated with 800nm laser excitation light from the adventitial side with an 
infrared camera (FLIR SC4000) viewing the intima surface. Regions with increased infrared 
radiometric temperature in response to 800nm laser excitation light were identified as “hot 
spots” in recorded images [Fig. 1(b)]. Hot spot locations were identified and the specimens 
were positioned in the photothermal OCT setup for M-mode imaging. Care was exercised to 
ensure  relative  position  of  the  tissue  specimen  and  800nm  laser  excitation  light  was 
unchanged for infrared imaging and photothermal OCT M-mode imaging. The non-balloon 
injured thoracic aorta served as the control for each rabbit and were imaged using infrared and 
photothermal  OCT  in  a  similar  manner  as  the  macrophage-rich  abdominal  aorta.  Prior  to 
recording M-mode images,  the photothermal OCT beam  was  focused to a 20-µm  spot at 
approximately 200-µm under the air-tissue interface. The 800nm laser excitation beam (2mm 
spot  diameter)  was  oppositely  directed  and  co-registered  to  the  photothermal  OCT  probe 
beam [Fig. 1(a)]. Tissue specimens were irradiated by intensity-modulated (50 Hz, 50% duty 
cycle,  2W  average  power)  800  nm  laser  light  over  a  two-second  time  period  while 
photothermal  OCT  M-mode  images  consisting  of  40,000  A-scans  were  recorded.  In  both 
infrared  and  photothermal  OCT  M-mode  imaging  experiments,  maximum  radiometric 
temperature was maintained below 30°C to avoid protein denaturation and dehydration. After 
photothermal OCT M-mode imaging, OP (δ(z,t)) variation and OPMA (δ(z,fl)) were computed 
and tissue specimens were placed in formalin and processed for histology. 
2.5 Histological analysis and fluorescence imaging 
Processed tissue specimens were cut into 5 µm thick sections and stained with hematoxylin 
and eosin for general structure identification and RAM-11 (Dako Anti-Rabbit Macrophage 
Clone RAM11) for macrophage cell identification. Paired sections were prepared for darkfield 
microscopy  to  detect  the  presence  of  nanorose.  Tissue  sections  were  imaged  with  light 
microscopy  using  a  Leica  DM6000  upright  light  microscope  fitted  with  a  Spot  IDEA 
digitizing camera coupled to a computer with image acquisition software. Brightfield images 
were captured and recorded for adjacent sections stained with hematoxylin and eosin and 
RAM  11.  Darkfield  microscopy  was  similarly  performed  after  substituting  a  Zeiss  X278 
darkfield condenser for the brightfield condenser. To take advantage of difference in optical 
properties between nanorose and native aortic plaque components, a 610 nm long pass filter 
was  positioned  in  the  imaging  path  of  the  microscope  to  attenuate  reflected  light  with 
wavelengths shorter than 610 nm. 
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3.1 Tissue phantom photothermal OCT measurements 
 
Fig. 2. OP variation (δ (z = 0,t)) of the air-phantom interface of control (black) and nanorose 
(grey) tissue phantom (6.3 x10
9 nanoroses/ml) measured by photothermal OCT in response to 
intensity-modulated (fl = 50 Hz) laser (800nm) excitation. 
3.1.1 Phantom photothermal OCT surface measurements 
OP variation (δ(z,t)) of the air-phantom interface (z = 0) in the control and tissue phantoms 
containing  nanorose  were  computed  from  recorded  photothermal  OCT  M-mode  images  
(Fig. 2). Phantoms containing nanorose exhibit greater OP variation (δ (z = 0,t)) than the 
control  phantom  (without  nanorose)  in  response  to  laser  (800nm)  excitation.  Plot  of  OP 
variation  vs.  time  (Fig.  2)  indicates  a  distinct  50  Hz  oscillation  is  observed  in  nanorose 
phantoms that is not evident in controls. 
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Fig. 3. OPMA (δ(z = 0,fl)) of the air-phantom interface vs. nanorose concentration computed 
from photothermal OCT M-mode images in response to intensity-modulated (fl = 50 Hz) laser 
(800nm) excitation ( × ). Solid line is linear least squares fit. 
Experiments  were  performed  with  tissue  phantoms  containing  nanorose  at  various 
concentrations:  6.4  x10
9  nanoroses/ml,  3.2  x10
9  nanoroses/ml,  3.2x10
8  nanoroses/ml  and 
3.2x10
7 nanoroses/ml. OPMA (δ(z = 0,fl)) at the air-phantom interface was computed from 
recorded photothermal OCT M-mode images. Greatest OPMA (80 nm) at the air-phantom 
interface (z = 0) was observed in the tissue phantom with greatest nanorose concentration (6.4 
x10
9 nanoroses/ml). Tissue phantom with a concentration of 3.2x10
9 nanorose/ml showed a 
40nm OPMA at the air-phantom interface (z = 0). Tissue phantom with a concentration of 
3.2x10
8  nanoroses/ml  showed  an  OPMA  of  8nm  while  the  phantom  with  3.2x10
7 
nanoroses/ml showed an OPMA of 4nm at the air-phantom interface (z = 0). OPMA of the air-
phantom interface (z = 0) versus nanorose concentration (Fig. 3) suggests a linear relationship 
exists between OPMA at the air-phantom interface (z = 0) and nanorose concentration. A 
linear least squares fit indicates slope of the trend line is 1.0 x10
−8 nm·ml and an intercept of 
3.6 nm. Radiometric temperature increase of tissue phantoms in response to one modulation 
cycle of 800nm laser excitation was less than 0.064° C. 
3.1.2 Phantom photothermal OCT depth resolved measurements 
Depth resolved OPMA (δ(z,fl)) vs. optical depth (Fig. 4) in response to intensity-modulated (fl 
= 50Hz) laser (800 nm) excitation was recorded from four tissue phantoms containing variable 
nanorose  concentrations  (6.4  x10
9  nanoroses/ml;  3.2  x10
9  nanoroses/ml;  3.2  x10
8 
nanoroses/ml).  The  tissue  phantom  with  lowest  nanorose  concentration  (3.2x10
7 
nanoroses/ml) showed a negligible depth resolved OPMA and was not included our analysis. 
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Fig. 4. Depth resolved OPMA (δ(z,fl)) vs. optical depth (z) in tissue phantoms with variable 
nanorose concentration in response to intensity-modulated (fl = 50 Hz) laser (800nm) excitation 
(￿-6.4 x10
9 nanoroses/ml; × - 3.2 x10
9 nanoroses/ml; ￿-3.2 x10
8 nanoroses/ml) 
3.2 Rabbit aorta experiments 
3.2.1 Rabbit aorta photothermal OCT surface measurements 
We tested the ability of photothermal OCT to detect nanorose in response to laser excitation in 
macrophage-rich abdominal and macrophage-poor thoracic (paired control) aorta specimens. 
OPMA (δ(z,fl)) at the surface (z = 0) was computed from recorded photothermal OCT M-
Mode images of macrophage-rich and control rabbit aorta specimens. Depth resolved OPMA 
(δ(z,fl)) was also computed and is described in the next section. OPMA (δ(z,fl)) at the surface 
(z = 0) of macrophage-rich abdominal aorta containing nanorose is approximately five-fold 
larger than that in controls (Fig. 5). 
 
Fig. 5. OP (δ(z = 0,t)) variation at the surface (z = 0) in macrophage-rich and control rabbit 
aorta specimens. 
OP variation (δ(z = 0,t)) of the air-tissue interface (z = 0) of macrophage-rich and control 
rabbit aorta was computed from recorded photothermal OCT M-mode images (Fig. 5). OP 
variation shows a distinct 50 Hz oscillation in the macrophage-rich abdominal aortic sample 
that is smaller in control thoracic aorta. The macrophage-rich abdominal rabbit aorta with 
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rabbit aorta showed an average OPMA of δ(z = 0,fl) = 3nm. 
3.2.2 Rabbit aorta depth resolved photothermal OCT measurements 
Depth resolved OPMA in response to laser (800 nm) excitation recorded from macrophage-
rich and control rabbit aorta specimens was calculated from recorded photothermal OCT M-
mode images. Figure 6 demonstrates OPMA (δ(z,fl)) vs. optical depth from macrophage-rich 
and control specimens (A: Abdominal (macrophage-rich) and T: Thoracic (control)). OPMA 
magnitude and slope is distinctively different for macrophage-rich versus control specimens. 
Magnitude of OPMA in macrophage-rich abdominal aorta tissue specimens is 2.5-5.0x larger 
than  in  control  thoracic  aorta  specimens.  For  macrophage-rich  abdominal  aorta  tissue 
specimens, slope of δ(z,fl) is reduced and OPMA does not decrease significantly (<15%) with 
increasing depth (Fig. 6). In comparison, in control thoracic aorta specimens, slope of δ(z,fl) is 
more negative and OPMA shows a more rapid decrease (more than 70%) with increasing 
optical depth (Fig. 6). At the deepest optical depths (z = 400 m), OPMA of macrophage-rich 
abdominal  aorta  specimens  is  5X  larger  than  that  in  control  thoracic  tissues.  Observed 
differences  in  magnitude  and  slope  of  δ(z,fl)  suggests  that  depth-resolved  photothermal 
response is distinctly different between macrophage-rich and control aortas. 
Statistical differences in OPMA (nm) versus optical depth (mm) of macrophage-rich and 
control rabbit aortas were performed (Fig. 6). A two-sided test with a significance level of 5% 
and  predicted  values  estimated  based  on  a  repeated  measures  linear  model  in  terms  of 
location, optical depth, and the optical depth by location interaction with an autoregressive 
order-one correlation assumption [SAS Version 9.1 for Windows, SAS Institute, Cary, North 
Carolina]. For each anatomical location, whiskers extend to the predicted value plus or minus 
one  standard  error  [Abdomen:  Black,  Thorax:  Red].  The  location  effect  (p  =  0.002)  and 
optical  depth  by  location  interaction  (p  =  0.03)  were  significant  indicating  a  statistically 
significant difference between macrophage-rich and control aorta with optical depth in both 
mean OPMA and OPMA slope. 
 
Fig.  6.  Replicate  OPMA  (nm)  and  optical  depth  (microns)  measurements  in  three  rabbits 
measured in each of two anatomical locations [A: Abdomen (injured), T: Thorax (control)] at 
up to six different depths. Animals are identified by color (blue, green, orange) and replicates 
by symbol (triangle, dot). 
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Histological images of macrophage-rich tissue sections from a double balloon-injured, fat fed 
New Zealand white rabbit injected 3 days before sacrifice with intravascular nanorose at a 
dose  of  1.4mg  Au/kg  body  weight  confirms  an  area  rich  in  macrophages  in  the  intimal 
hyperplasia by positive RAM 11 (brown color) stain (Fig. 7). A lack of RAM 11 stain, and 
thus an absence of macrophages, is observed in the control. Nanorose are identified in 610 nm 
longpass-filtered darkfield microscopy images as bright red reflections on a dark background. 
The relative absence of highly-reflective constituents compared to control and macrophage-
rich tissue sections coupled with enhanced reflectivity of nanorose at wavelengths longer than 
610nm is responsible for bright areas observed in darkfield microscopy images. In Fig. 7, 
images of macrophage-rich tissue sections are positive for nanorose while the control tissue is 
negative. Taken together with RAM 11 results, microscopy images suggest that macrophage-
rich abdominal aorta tissues contain nanoroses, while the control thoracic aorta specimens 
contain neither macrophages nor nanorose. 
 
Fig.  7.  Microscopy  images  of  macrophage-rich  and  control  sections.  Macrophage-rich 
abdominal (left column) and control thoracic aorta (right column); Brightfield RAM-11 stained 
(top Row) and darkfield (bottom row) unstained microscopy images. Scale bar = 50 microns. 
4. Discussion 
4.1Tissue phantom photothermal OCT measurements 
From recorded photothermal OCT M-mode images of tissue phantoms we computed OPMA 
at  the  air-phantom  interface  (z  =  0)  and  depth  resolved  variation  for  increasing  nanorose 
concentrations.  We  present  analytical  models  of  both  surface  and  depth-resolved  OPMA 
measurements and interpret our results. 
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A linear relationship is observed (Fig. 3) between OPMA of the air-phantom interface and 
nanorose concentration. Slope of the line is related to nanorose concentration while a non-
negative y-intercept suggests that PDMS phantoms exhibit some residual absorption without 
any nanorose. The result supports our hypothesis that thermoelastic expansion is caused in 
large part by the selective absorption of incident laser (800nm) radiation by nanorose. Kim et 
al. [32] presented an algebraic expression for the one-dimensional thermoelastic displacement 
of a laser heated specimen. OPMA at the air-phantom interface is given by Eq. (1). 
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where α is thermoelastic expansion, υ  is Poisson’s ratio and δ (z = l0,fl) is the OPMA at the 
air-phantom interface (Fig. 6). In this equation, the phantom is on a glass slide with position 
of  the  glass-phantom  interface  at  z  =  0.  Phantom  thickness  is  given  by  l0  while  the  air-
phantom  interface  is  at  z  =  l0.  The  temperature  increase  ( Tfl)  in  the  phantom  over  one 
modulation cycle of 800nm laser excitation is given by Eq. (2): 
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where   Tlf(z)  is  the  depth-resolved  temperature  rise  over  one  modulation  cycle  of  laser 
excitation, σ is the nanorose absorption cross section, N is nanorose concentration, Φ(z is 
depth resolved optical fluence rate, ρC is the volumetric heat capacity of PDMS, and  PDMS is 
the  absorption  coefficient  of  PDMS  without  nanorose.  Monte  Carlo  simulations  were 
performed to assess the depth-dependence (z) of optical fluence rate (Φ(z) and suggest that for 
thin phantoms (250 microns) used in our experiments, the optical fluence rate (Φ) is nearly 
constant in depth (z). Taking into account the above assumptions OPMA at the air-phantom 
interface is given by 
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Substituting a Poisson’s ratio of υ  = 0.5, predicted slope (d
dN
δ ) of the best-fit line in 
Fig. 3 is given by Eq. (4). 
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where fl is the frequency of laser intensity modulation. The absorption cross section (σ = 3.1 ± 
0.5 x10
−14 m
2) of the nanoparticles was measured using an approach employing an integrating 
sphere [33]. The laser spot size was measured using a knife edge test and the resultant optical 
fluence rate (Φ) of 64 W/cm
2 was estimated. Thermoelastic expansion coefficient (α) of the 
PDMS is 310ppm/◦C [34] and phantoms were lo = 250 microns thick. The volumetric heat 
capacity (ρC) of PDMS was taken as 1447.5x10
3 J/(m
3K) [35]. 
Using Eq. (4), values specified above and accounting for uncertainty of  the  measured 
nanorose absorption cross section, computed OPMA at the air-phantom interface per unit 
nanorose concentration is  d
dN
δ  = 1.05 ± 0.25·10
−8 nm-ml. From the plot in Fig. 3, slope of 
the best fit line is 1.0x10
−8 nm-ml. Computed OPMA at the air-phantom interface per unit 
nanorose concentration values deduced from Eq. (4) (1.05 ± 0.25·10
−8 nm-ml) and experiment 
(1.0x10
−8 nm-ml) are consistent within experimental error of the nanorose absorption cross 
section measurement. 
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Fig. 8. Phantom and scatterer 
Figure  8  shows  a  cartoon  of  the  tissue  phantom  with  thickness  (l0)  on  a  glass  slide 
substrate  with  a  scattering  center  positioned  at  a  distance  ‘z’  above  the  glass-phantom 
interface. When laser light is absorbed and heats the phantom, OP variation occurs. For a 
scattering center at a distance z above the glass-phantom interface, the change in OP of light 
backscattered from the scattering center as a result of a temperature increase ( T) is given by, 
  0 0 0 ( , )  [( 1)       –   (   )] l o
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z f n l l z n T
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δ δ
δ α α
δ δ
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Where  T is given by Eq. (2) with Φ(z) = Φo. Eq. (5) is derived by considering change in OP 
due  to  thermoelastic  expansion  and  change  of  the  refractive  index  due  to  temperature 
( n
T
δ
δ ). In Eq. (5), δ > 0 (δ < 0) indicates an increase (decrease) in optical pathlength. At the 
air-phantom interface (z = lo) Eq. (5) simplifies to the well-known result, 
  0 0 (   , )   l z l f l T δ α = = −      (6) 
For  a  positive  temperature  increase  ( T  >  0),  change  in  OP  (δ(z  =  l0,fl))  is  negative 
indicating  a  reduced  optical  pathlength.  Depth-resolved  OPMA  of  tissue  phantoms  was 
computed  and  plotted  (Fig.  4).  Slope  of  fitted  lines  (Fig.  4)  provide  measured  values  of 
OPMA per unit depth. To calculate the predicted value of OPMA per unit depth, Eq. (5) was 
used. In the first step, the value of ( o
n
n
T
δ
α
δ
+ ) was calculated as 3.37 × 10
−4. The surface 
displacement  corresponding  to  different  nanorose  concentrations  and  the  value  of 
( o
n
n
T
δ
α
δ
+ ), were then used to calculate the expected temperature increase in the phantoms 
over one cycle of laser excitation. Using the value of ( o
n
n
T
δ
α
δ
+ ) and the actual temperature 
rise, the OPMA per unit optical depth was calculated from Eq. (5) and a measured value of 
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calculated value of OPMA per unit depth for different phantoms. 
Table 1. OPMA per unit depth (calculated and measured) for different concentrations 
Concentration of 
nanoparticles in 
phantom 
(nanorose/ml) 
OPMA per unit 
optical depth 
(calculated 
nm/mm) 
OPMA per unit 
optical depth 
(measured 
nm/mm) 
6.4 × 10
9  0.25  0.27 
3.2 × 10
9  0.15  0.14 
3.2 × 10
8  0.02  0.02 
4.2 Rabbit aorta tissue photothermal OCT measurements 
4.2.1 Rabbit aorta tissue photothermal OCT surface measurements 
Figure 7 and results described in section 3.2.1 suggest that nanoparticles were selectively 
engulfed by macrophage rich abdominal rabbit aorta. Determining the nanorose concentration 
in aorta sections could be of significant clinical interest for nanoparticle dosimetry studies, 
where  the  greater  the  macrophage  density,  the  more  vulnerable  the  plaque  is  to  rupture 
resulting in clinical events. Macrophage rich abdominal aorta sections exhibit an OPMA (9-
12nm) and control thoracic aorta sections exhibit a smaller OPMA (2-3 nm) at the air-tissue 
interface.  The  OPMA  due  to  nanorose  is  taken  as  the  difference  between  abdominal  and 
control OPMA. To estimate the concentration of nanoparticles in the abdominal aorta section, 
we  use  the  OPMA  model  presented  in  section  4.1.1.  Several  assumptions  were  made  in 
deriving this equation, namely a uniform optical fluence, a uniform sample thickness, uniform 
volumetric heat capacity, and a uniform spatial distribution of nanoparticles. Also thickness of 
the phantoms was 250  m while the histology studies indicated that nanoparticle layers in 
aorta were about 200  m. To estimate nanorose concentration is tissue, we scale the slope 
measured  in  phantoms  (0.8x10
−8  nm⋅ml)  to  account  for  different  thicknesses  between 
nanorose in tissue and phantoms. In absence of reliable values for the coefficient of thermal 
expansion and volumetric heat capacity of aorta, values for cardiac muscle of rabbit [36] were 
used and an estimate of OPMA per unit concentration of nanoparticles in aortic tissue was 
estimated as 4.32x10
−9 nm-ml. Accounting for all the simplifying assumptions, and using the 
measured  OPMA  in  macrophage-rich  and  control  aorta  specimens  and  the  extrapolated 
OPMA  per  unit  concentration  of  nanoparticles,  for  the  first  time  localized  nanorose 
concentration can be estimated at the probed site in the macrophage-rich abdominal aorta 
sections as 8ppm (2.5x10
9 particles/ml). 
4.2.2 Rabbit aorta tissue photothermal OCT depth resolved measurements 
OPMA of control thoracic aortas (Fig. 6) is observed to decrease with increasing depth (z). 
The observed decrease in OPMA (δ(z,fl))  with increasing optical  depth (z) is  similar  to  that 
observed in tissue phantoms with a uniform absorption profile. Histology of control thoracic 
aortas did not exhibit a high concentration of macrophages. Inasmuch as aortic tissue can 
absorb  800nm  light,  some  component  of  OPMA  is  due  to  absorption  by  endogenous 
chromophores as  was observed in experiments  with tissue phantoms. Because the control 
thoracic aortic tissue is believed to absorb laser light (800 nm) homogenously, OPMA is 
expected to decrease linearly with increasing depth as observed in experiments with tissue 
phantoms. 
OPMA of macrophage-rich aortas (Fig. 6) is not observed to decrease significantly with 
increasing depth (z). The flat OPMA profile observed in macrophage-rich abdominal aorta 
tissues  suggests  a  non-uniform  distribution  of  nanoroses  may  be  present.  Moreover, 
significant OPMA is observed at optical depths as deep as 400  m in aorta sections. 
Nanoroses can enter the aortic  wall either through  the  lumen or vasa vasorum. When 
nanorose enter through the lumen, we expect an increased concentration of nanoparticles near 
the luminal surface. When nanorose enter through the vasa vasorum, we expect increased 
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pathways, we expect and the histology demonstrates that deposition of nanorose in abdominal 
aorta can exhibit a non-uniform distribution. The flat OPMA vs. depth (z) profile may be due 
to presence of nanorose at deeper depths that are delivered through the vasa vasorum. Further, 
the  deposition  of  the  macrophages  is  not  homogenous  but  is  variable,  which  can  also 
contribute to the non-uniform distribution of the nanorose. 
In the rabbit aorta and tissue phantom experiments, we assumed a constant optical fluence 
distribution. However, in practice, the fluence in tissue is not uniform and will need to be 
examined  to  analyze  depth-resolved  OPMA  measurements  in  macrophage-rich  aorta.  We 
assumed a uniform volumetric heat capacity for phantoms and aorta. This assumption is an 
oversimplification  since  the  volumetric  heat  capacity  of  tissues  can  change  with  tissue 
constituents. Particularly, the volumetric heat capacity can have a strong dependence on the 
lipid  concentration.  Photothermal  OCT  requires  the  selection  of  an  excitation  laser  of 
appropriate wavelength to excite target chromophores. However, because the distribution of 
chromophores is not uniform in tissue, our models of depth-resolved OPMA require some 
generalization  for  non-uniform  nanorose  distributions  before  applying  to  macrophage-rich 
abdominal aorta. 
We have demonstrated that by using photothermal OCT, depth-resolved OP variation may 
be measured for the first time in ex vivo tissue preparations, and we derived a relationship 
between  OP  and  nanorose  concentration.  Knowledge  of  the  correlation  between  nanorose 
concentration and OPMA can be used to develop a method to estimate nanorose concentration 
in macrophages, which is of interest since vulnerable plaques known to rupture and result in 
clinical  events  have  greater  density  of  macrophages.  However,  development  of  such  an 
approach  requires  further  experimentation  and  development.  First,  experiments  must  be 
performed on phantoms  with a non-uniform distribution  of nanorose. Second, an imaging 
equation that generalizes the result given in Eq. (6) must be developed for the case when 
nanorose  concentration  may  vary  with  depth.  Third,  finding  a  solution  to  this  imaging 
equation from recorded photothermal OCT  measurements may allow determination of the 
concentration profile of a targeted chromophore (e.g. nanorose). 
5. Conclusions 
We present for the first time both surface and depth-resolved OP variation measurements 
using photothermal OCT in tissues and phantoms containing nanoroses and a quantitative 
interpretation of the results. Using photothermal OCT and ‘nanorose’ with a size between 30 
and 50nm, nanoparticle absorption begins to dominate over scattering. Because photothermal 
OCT is based on absorption rather than scattering the approach described may allow use of 
nanorose as an optical contrast agent for clinical diagnostics. Tissue phantoms containing 
nanorose exhibited greater thermoelastic displacement than that observed in controls without 
nanorose.  Values  of  OP  variation  measured  using  photothermal  OCT  per  unit  nanorose 
concentration deduced from experiment are in quantitative agreement with predicted values. 
The ex vivo rabbit aorta exhibited a similar trend to that observed in tissue phantoms. Aortic 
tissue with engulfed nanorose (abdominal aorta) exhibited a statistically greater OP variation 
as  compared  to  aortic  tissue  sections  containing  fewer  nanoroses  (thoracic  aorta).  We 
conclude that atherosclerotic aortic regions with increased OPMA for incident 800nm laser 
excitation may be attributed to specific targeting of nanoroses of macrophage cells associated 
with plaque and nanorose concentration may be non-uniform. Further studies are required to 
develop  an  approach  to  estimate  depth  profile  of  nanorose  concentration  from  recorded 
photothermal OCT measurements. 
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